References
- Srertz G. Polymyositis. Berl Klin Wochenshr 1916; 53:489
- Posner JB, Furneaux HM. Paraneoplastic syndromes. In: Waksman BH, ed. Immunologic mechanisms in neurologic and psychiatric disease. New York: Raven, 1990: 187–219
- Darnell RB. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci USA 1996; 93(10): 4529–36
- Musunuru K, Darnell RB. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci 2001; 24: 239–62
- Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999; 56(4): 405–8
- Rosenthal AK, McLaughlin JK, Gridley G, et al. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76(5): 910–4
- Tishler M, Shoenfeld Y. Paraneoplastic syndromes. In: Shoenfeld Y, Gershwin ME, eds. Cancer and autoimmunity. Amsterdam: Elsevier Science, 2000; 121–33
- Esbrit P. Hypercalcemia of malignancy—new insights into an old syndrome. Clin Lab 2001; 47 (1–2): 67–71
- Abu-Shakra M, Buskila D, Ehrenfeld M, et al. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001; 60(5): 433–41
- Albert ML, Darnell JC, Bender A, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998; 4(11): 1321–4
- Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357(9250): 96–100
- Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheumatol 2000; 12(6): 498–500
- Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study. Ann Intern Med 2001; 134(12): 1087–95
- Yazici Y, Kagen LJ. Malignancy and rheumatic disorders. Available at: http://www.uptodate.com. Accessed May 28, 2001
- Carson S. The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol 1997; 24(3): 360–72
- Riise T, Jacobsen BK, Gran JT, et al. Total mortality is increased in rheumatoid arthritis: a 17-year prospective study. Clin Rheumatol 2001; 20(2): 123–7
- Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansions. Blood 1998; 91(6): 1864–72
- Stummvoll GH, Aringer M, Machold KP, et al. Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms: report of two cases and review of the literature. Scand J Rheumatol 2001; 30(1): 40–4
- Sridhar KS, Lobo CF, Altman RD. Digital clubbing and lung cancer. Chest 1998; 114(6): 1535–7
- Silveira LH, Martinez-Lavin M, Pineda C, et al. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18(1): 57–62
- Jajic Z, Grazio S, Nemcic T, et al. Reactivation of primary hypertrophic osteoarthropathy by bronchogenic carcinoma. Clin Exp Rheumatol 2001; 19(1): 95–7
- Orts D, Hernandez L, Barroso E, et al. Hypertrophic osteoarthropathy in lung cancer: Are the radiographic bone changes reversible after curative resection! Monaldi Arch Chest Dis 2000; 55(2): 122–3